Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Richard W. Joseph, Alicia C. Shillington, Todd A. Lee, Cynthia P. Macahilig, Scott J. Diede, Vaidehi Dave, Qing Harshaw, Emilie Scherrer & Frank Xiaoqing Liu. (2020) Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers. Journal of Medical Economics 23:2, pages 132-138.
Read now
Read now
Ching Tung Lum, Longfei Huo, Raymond Wai-Yin Sun, Ming Li, Hsiang Fu Kung, Chi-Ming Che & Marie C. M. Lin. (2011) Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis. Acta Oncologica 50:5, pages 719-726.
Read now
Read now
Atsushi Tanemura, Anneke Q van Hoesel, Takuji Mori, Terrance Yu & Dave SB Hoon. (2007) The role of estrogen receptor in melanoma. Expert Opinion on Therapeutic Targets 11:12, pages 1639-1648.
Read now
Read now
Omar Khan & Mark R Middleton. (2007) The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors. Expert Opinion on Investigational Drugs 16:10, pages 1573-1584.
Read now
Read now
Articles from other publishers (46)
Shunzhe Zheng, Guanting Li, Jianbin Shi, Xinying Liu, Meng Li, Zhonggui He, Chutong Tian & Ken-ichiro Kamei. (2023) Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release 361, pages 819-846.
Crossref
Crossref
Chongchao Hou, Qiang Wu, Lizhou Xu, Rongwei Cui, Rongying Ou, Danyang Li & Yunsheng Xu. (2022) Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Jyoti Bajpai, George Abraham, Avanish P. Saklani, Anshul Agarwal, Sashanka Das, Ambarish Chatterjee, Akhil Kapoor, Prathyusha Eaga, Pradip Kumar Mondal, Arun Chandrasekharan, Prabhat Ghanshyam Bhargava, Sujay Srinivas, Siddharth Turkar, Bharat Rekhi, Nehal Khanna, Amit Kumar Janu, Munita Bal, Vikas Sureshchand Ostwal, Anant Ramaswamy, Jitender Rohila, Ashwin L. Desouza, Amrita Guha, Rajiv Kumar, Nandini Sharrel Menon, Sushmita Rath, Vijay Maruti Patil, Vanita Maria Noronha, Amit Prakashchandra Joshi, Siddhartha Laskar, Venkatesh Rangarajan, Kumar Prabhash, Sudeep Gupta & Shripad Banavali. (2021) Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India. Frontiers in Oncology 11.
Crossref
Crossref
Koichiro Kumano, Tsuyoshi Enomoto, Daichi Kitaguchi, Yohei Owada, Yusuke Ohara & Tatsuya Oda. (2020) Intussusception induced by gastrointestinal metastasis of malignant melanoma: A case report. International Journal of Surgery Case Reports 71, pages 102-106.
Crossref
Crossref
Yukihiro Takayasu, Nobuteru Kubo, Masato Shino, Osamu Nikkuni, Shota Ida, Atsushi Musha, Katsumasa Takahashi, Junko Hirato, Katsuyuki Shirai, Jun‐ichi Saitoh, Satoshi Yokoo, Kazuaki Chikamatsu, Tatsuya Ohno & Takashi Nakano. (2019) Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study. Cancer Medicine 8:17, pages 7227-7235.
Crossref
Crossref
Teodora Nikolova, Wynand P. Roos, Oliver H. Krämer, Herwig M. Strik & Bernd Kaina. (2017) Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 29-39.
Crossref
Crossref
Akihiko Sano, Hitoshi Ojima, Daigo Ozawa, Atsushi Ogawa, Hiroyuki Ando, Makoto Sohda, Yasuyuki Fukai, Yasushi Mochida & Hiroyuki Kuwano. (2016) Clinical significance of [18F]-fluoro-deoxy-glucose positron emission tomography/computed tomography in patients with primary malignant melanoma of the esophagus: report of three cases. Esophagus 13:3, pages 311-316.
Crossref
Crossref
Liv-Marie Eike, Nannan Yang, Øystein Rekdal & Baldur Sveinbjørnsson. (2015) The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells. Oncotarget 6:33, pages 34910-34923.
Crossref
Crossref
Annette Geltmeier, Beate Rinner, Dennis Bade, Katharina Meditz, Reiner Witt, Uwe Bicker, Catrin Bludszuweit-Philipp & Patrick Maier. (2015) Characterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic Analyses. PLOS ONE 10:8, pages e0134999.
Crossref
Crossref
Mohamed Hassan. (2015) Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatment. World Journal of Experimental Medicine 5:4, pages 206.
Crossref
Crossref
Ravi P. Sahu, Matheus Ferracini & Jeffrey B. Travers. (2015) Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists. Mediators of Inflammation 2015, pages 1-6.
Crossref
Crossref
Ketil André Camilio, Gerd Berge, Chandra Sekhar Ravuri, Øystein Rekdal & Baldur Sveinbjørnsson. (2014) Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315. Cancer Immunology, Immunotherapy 63:6, pages 601-613.
Crossref
Crossref
Angelica Conversano, Simona Macina, Rocco Indellicato, Domenico Lacavalla & Dario D’Abbicco. (2014) Gastrointestinal bleeding as presentation of small bowel metastases of malignant melanoma: Is surgery a good choice?. International Journal of Surgery Case Reports 5:10, pages 774-778.
Crossref
Crossref
T. Matsumoto, K. Yokota, M. Sawada, A. Sakakibara, S. Shibata, S. Yasue, Y. Tomita, H. Yatsuya & M. Akiyama. (2013) Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly. Journal of the European Academy of Dermatology and Venereology 27:12, pages 1514-1520.
Crossref
Crossref
A Tanemura, E Kiyohara, I Katayama & Y Kaneda. (2013) Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application. Cancer Gene Therapy 20:11, pages 599-605.
Crossref
Crossref
Sang-Woon Lee, Seong-Gon Kim, Young-Wook Park, HaeYong Kweon, Jwa-Young Kim & Horatiu Rotaru. (2013) Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study. Tumor Biology 34:3, pages 1595-1603.
Crossref
Crossref
Catalin Mihalcioiu. 2013. Experimental and Clinical Metastasis. Experimental and Clinical Metastasis
299
318
.
Anand Rotte, Magdalena Martinka & Gang Li. (2012) MMP2 expression is a prognostic marker for primary melanoma patients. Cellular Oncology 35:3, pages 207-216.
Crossref
Crossref
Tillmann Schill, Michael P. Schön, Nadin Pletz, Steffen Emmert & Margarete Schön. (2011) Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP‐2 and effect on melanoma metastasis to the lung. Experimental Dermatology 21:2, pages 91-98.
Crossref
Crossref
Daniela Senft, Carola Berking, Saskia A. Graf, Claudia Kammerbauer, Thomas Ruzicka & Robert Besch. (2012) Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1. PLoS ONE 7:1, pages e30821.
Crossref
Crossref
Camila Ferreira de Souza, Alice Santana Morais & Miriam Galvonas Jasiulionis. (2012) Biomarkers as Key Contributors in Treating Malignant Melanoma Metastases. Dermatology Research and Practice 2012, pages 1-14.
Crossref
Crossref
Yoshimi Iwanuma, Natsumi Tomita, Takayuki Amano, Fuyumi Isayama, Masahiko Tsurumaru, Takuo Hayashi & Yoshiaki Kajiyama. (2011) Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. Journal of Gastroenterology 47:1, pages 21-28.
Crossref
Crossref
Li-Te Lin, Chung-Bin Liu, San-Nung Chen, An-Jen Chiang, Wen-Shiung Liou & Ken-Jen Yu. (2011) Primary malignant melanoma of the vagina with repeated local recurrences and brain metastasis. Journal of the Chinese Medical Association 74:8, pages 376-379.
Crossref
Crossref
Claus GarbeThomas K. EigentlerUlrich KeilholzAxel HauschildJohn M. Kirkwood. (2011) Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects. The Oncologist 16:1, pages 5-24.
Crossref
Crossref
T.K. Eigentler, F. Meier, U. Keilholz, A. Hauschild & C. Garbe. (2010) Systemische Therapie des metastasierten MelanomsSystemic therapy of metastized melanoma. Der Onkologe 16:12, pages 1160-1166.
Crossref
Crossref
Di Bei, Tao Zhang, James B. Murowchick & Bi-Botti C. Youan. (2010) Formulation of Dacarbazine-loaded Cubosomes. Part III. Physicochemical Characterization. AAPS PharmSciTech 11:3, pages 1243-1249.
Crossref
Crossref
C. Mangas, C. Paradelo, S. Puig, F. Gallardo, J. Marcoval, A. Azon, R. Bartralot, S. Bel, X. Bigatà, N. Curcó, J. Dalmau, L.J. del Pozo, C. Ferrándiz, M. Formigón, A. González, M. Just, A. Llambrich, E. Llistosella, J. Malvehy, R.M. Martí, M.E. Nogués, R. Pedragosa, V. Rocamora, M. Sàbat & M. Salleras. (2010) Valoración inicial, diagnóstico, estadificación, tratamiento y seguimiento de los pacientes con melanoma maligno primario de la piel. Documento de consenso de la “Xarxa de Centres de Melanoma de Catalunya i Balears”. Actas Dermo-Sifiliográficas 101:2, pages 129-142.
Crossref
Crossref
C. Mangas, C. Paradelo, S. Puig, F. Gallardo, J. Marcoval, A. Azon, R. Bartralot, S. Bel, X. Bigatà, N. Curcó, J. Dalmau, L.J. del Pozo, C. Ferrándiz, M. Formigón, A. González, M. Just, A. Llambrich, E. Llistosella, J. Malvehy, R.M. Martí, M.E. Nogués, R. Pedragosa, V. Rocamora, M. Sàbat & M. Salleras. (2010) Initial Evaluation, Diagnosis, Staging, Treatment, and Follow-up of Patients with Primary Cutaneous Malignant Melanoma. Consensus Statement of the Network of Catalan and Balearic Melanoma Centers. Actas Dermo-Sifiliográficas (English Edition) 101:2, pages 129-142.
Crossref
Crossref
Merlin Guggenheim, Pietro Giovanoli, Brigitta G. Baumert, Thomas Kurt Eigentler, Claus Garbe, Joanna Mangana & Reinhard Dummer. 2011. Skin Cancer - A World-Wide Perspective. Skin Cancer - A World-Wide Perspective
307
341
.
Mario Bigioni, Massimo Parlani, Alessandro Bressan, Daniela Bellarosa, Licia Rivoltini, Fabio Animati, Attilio Crea, Rossana Bugianesi, Carlo Alberto Maggi, Stefano Manzini & Monica Binaschi. (2009) Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants. International Journal of Cancer 125:10, pages 2456-2464.
Crossref
Crossref
Jens Atzpodien, Lars Morawek, Michael Fluck & Martina Reitz. (2009) Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients. Cancer Chemotherapy and Pharmacology 64:5, pages 901-905.
Crossref
Crossref
Di Bei, Jacob Marszalek & Bi-Botti C. Youan. (2009) Formulation of Dacarbazine-Loaded Cubosomes—Part I: Influence of Formulation Variables. AAPS PharmSciTech 10:3.
Crossref
Crossref
Charles O. Noble, Zexiong Guo, Mark E. Hayes, James D. Marks, John W. Park, Christopher C. Benz, Dmitri B. Kirpotin & Daryl C. Drummond. (2009) Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine. Cancer Chemotherapy and Pharmacology 64:4, pages 741-751.
Crossref
Crossref
Marko Lens, Veronique Bataille & Zoran Krivokapic. (2009) Melanoma of the small intestine. The Lancet Oncology 10:5, pages 516-521.
Crossref
Crossref
Paola Nisticò, Imerio Capone, Belinda Palermo, Duilia Del Bello, Virginia Ferraresi, Federica Moschella, Eleonora Aricò, Mara Valentini, Laura Bracci, Francesco Cognetti, Mariangela Ciccarese, Giuseppe Vercillo, Mario Roselli, Emanuela Fossile, Maria Elena Tosti, Ena Wang, Francesco Marincola, Luisa Imberti, Caterina Catricalà, Pier Giorgio Natali, Filippo Belardelli & Enrico Proietti. (2009) Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients. International Journal of Cancer 124:1, pages 130-139.
Crossref
Crossref
Margarete Schön, B. Gregor Wienrich, Susanne Kneitz, Helga Sennefelder, Katharina Amschler, Verena Vöhringer, Olaf Weber, Thorsten Stiewe, Karl Ziegelbauer & Michael P. Schön. (2008) KINK-1, a Novel Small-Molecule Inhibitor of IKKβ, and the Susceptibility of Melanoma Cells to Antitumoral Treatment. JNCI: Journal of the National Cancer Institute 100:12, pages 862-875.
Crossref
Crossref
Yemin Wang, Derek L. Dai, Magdalena Martinka & Gang Li. (2007) Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma. Clinical Cancer Research 13:14, pages 4111-4116.
Crossref
Crossref
Andres ForeroJatin ShahRonda CarlislePierre L. TriozziAlbert F. LoBuglioWen-Quan WangMatt FujimoriRobert M. Conry. (2006) A Phase I Study of an Anti-GD3 Monoclonal Antibody, KW-2871, in Patients with Metastatic Melanoma. Cancer Biotherapy and Radiopharmaceuticals 21:6, pages 561-568.
Crossref
Crossref
Cara A. Rabik, Maria Chidiamara Njoku & M. Eileen Dolan. (2006) Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy. Cancer Treatment Reviews 32:4, pages 261-276.
Crossref
Crossref
Paolo A. AsciertoStefania ScalaGiuseppe CastelloAntonio DaponteEster SimeoneAlessandro OttaianoGerardo BeneduceVincenzo De RosaFrancesco IzzoMaria Teresa MelucciC. Mark EnsorArchie W. PrestaykoFrederick W. HoltsbergJohn S. BomalaskiMike A. ClarkNiramol SavarajLynn G. FeunTheodore F. Logan. (2005) Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies. Journal of Clinical Oncology 23:30, pages 7660-7668.
Crossref
Crossref
Yolanda Fernández, Monique Verhaegen, Thomas P. Miller, Jenny L. Rush, Philipp Steiner, Anthony W. OpipariJr.Jr., Scott W. Lowe & María S. Soengas. (2005) Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications. Cancer Research 65:14, pages 6294-6304.
Crossref
Crossref
Gunhild Keller, Andrew V. Schally, Timo Gaiser, Attila Nagy, Benjamin Baker, Gabriela Westphal, Gabor Halmos & Jörg B. Engel. (2005) Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue. Cancer Research 65:13, pages 5857-5863.
Crossref
Crossref
Shu-Jie He, Graham Stevens, Antony W. Braithwaite & Michael R. Eccles. (2005)
Transfection of melanoma cells with antisense
PAX3
oligonucleotides additively complements cisplatin-induced cytotoxicity
. Molecular Cancer Therapeutics 4:6, pages 996-1003.
Crossref
Crossref
Elena Solaz Moreno, Manuel Vallalta Morales, Gerardo Silla Búrdalo, Juan Ignacio Cervera Miguel, Roberto Díaz Beveridge & José Miguel Rayón Martín. (2005) Melanoma primario de recto: una neoplasia infrecuente con una forma de presentación atípicaPrimary melanoma of the rectum: an infrequent neoplasia with an atypical presentation. Clinical and Translational Oncology 7:4, pages 171-173.
Crossref
Crossref
Hui Q. Jiang, Yong Wang, Xin B. Hu, You S. Li & Jie S. Li. (2005) Composite Tissue Allograft Transplantation of Cephalocervical Skin Flap and Two Ears. Plastic and Reconstructive Surgery 115:3, pages 31e-35e.
Crossref
Crossref
Malcolm S. Mitchell. (2004) Chemotherapy for Melanoma: The Resultant of Conflicting Vectors. Journal of Clinical Oncology 22:11, pages 2043-2045.
Crossref
Crossref